Having a pediatric brain tumor is always a very serious matter, and a cerebellar low-grade astrocytoma is no exception. Cerebellar low-grade astrocytomas are tumors that arise in the cerebellum, the part of the brain that controls balance and coordination.
Most children and adolescents diagnosed with brain tumors survive into adulthood. Many of them face physical, psychological, social and intellectual challenges related to their treatment. They require ongoing care to help with school and with the skills they will use throughout adulthood.
Below, you’ll find detailed information about cerebellar low-grade astrocytomas. If you would like to read more general information about brain tumors, see our overview on pediatric brain tumors.
How Dana-Farber/Boston Children’s assesses cerebellar low-grade astrocytomas
Children with cerebellar low-grade astrocytomas receive comprehensive treatment through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, an integrated pediatric oncology program that provides—in one specialized program—all the services of both a leading pediatric cancer center and a pediatric hospital.
After treatment, your child will receive expert follow-up care through the Stop & Shop Pediatric Family Neuro-Oncology Outcomes Clinic at Dana-Farber/Boston Children’s, where he will be able to meet with his neurosurgeon, radiation oncologist, pediatric neuro-oncologist and neurologists at the same follow-up visit.
Our pediatric brain tumor clinic is held weekly. In addition to meeting with your pediatric neuro-oncologists, neurologist and neurosurgeon, your child also may need to see one of our endocrinologists or other subspecialists. School liaisons and psychosocial personnel from the pediatric brain tumor team also are available to see your child. If your child needs rehabilitation, they also may meet with speech, physical and occupational therapists during and after treatments.
“The largest predictor of how a child will do in an operation is not based on where the tumor is or how big it is. The No. 1 predictor is how experienced the neurosurgeon is in doing that operation in children.”
Mark Kieran, MD, PhD, director, Brain Tumor Center, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Reviewed by Peter Manley, MD
Boston Children’s Hospital, 2012